In:
BMJ Open, BMJ, Vol. 7, No. 10 ( 2017-10), p. e016053-
Abstract:
Subclinical hypothyroidism (SCH) has been associated with increased carotid intima-media thickness (C-IMT) in recent studies, but the effects of levothyroxine (L-T4) therapy on C-IMT in SCH patients are still controversial. Aim To evaluate the effect of L-T4 therapy on endothelial function as determined by C-IMT in patients with SCH. Methods BeforeJuly 2016, we searched the PubMed, Embase, Cochrane Library and Google Scholar databases, selecting published randomised controlled trials (RCTs) and self-controlled trials for the meta-analysis. Results Three RCTs with 117 patients were considered appropriate for the meta-analysis. The results of the meta-analysis indicated that L-T4 significantly decreased the development of C-IMT (weighted mean difference (WMD) −0.05 mm, 95% CI −0.08 to –0.01 mm; p=0.025). We also analysed nine studies (self-controlled trials) with 247 patients and extracted the IMT of SCH patients before and after L-T4 treatment. After L-T4 therapy, the pooled estimate of the WMD of decreased C-IMT was −0.04 mm (95% CI −0.07 to –0.02 mm; p=0.05). Subgroup analysis showed that L-T4 therapy was associated with a decrease in C-IMT among patients of mixed genders (WMD −0.03 mm, 95% CI −0.06 to –0.01 mm; p=0.145). L-T4 therapy was associated with a decrease in C-IMT among female patients (WMD −0.07 mm, 95% CI −0.14 to –0.01; p=0.186). Longer treatment ( 〉 6 months) also resulted in a significant decrease in C-IMT (WMD −0.05 mm, 95% CI −0.08 to –0.02; p=0.335). Conclusion This meta-analysis indicates that L-T4 treatment of SCH patients can reduce C-IMT, possibly as a result of the reduction of total cholesterol, triglyceride, low density lipoprotein, systolic blood pressure, diastolic blood pressure, lipoprotein(a), and flow-mediated dilatation. Decreased C-IMT was observed in SCH patients after long-term ( 〉 6 months) L-T4 treatment. RCTs with larger samples are needed to verify these observations.
Type of Medium:
Online Resource
ISSN:
2044-6055
,
2044-6055
DOI:
10.1136/bmjopen-2017-016053
DOI:
10.1136/bmjopen-2017-016053.supp1
DOI:
10.1136/bmjopen-2017-016053.supp2
DOI:
10.1136/bmjopen-2017-016053.supp3
DOI:
10.1136/bmjopen-2017-016053.supp4
DOI:
10.1136/bmjopen-2017-016053.supp5
DOI:
10.1136/bmjopen-2017-016053.supp6
Language:
English
Publisher:
BMJ
Publication Date:
2017
detail.hit.zdb_id:
2599832-8
Permalink